Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection

被引:26
作者
Fujii, N
Takenaka, K
Hiraki, A
Maeda, Y
Ikeda, K
Shinagawa, K
Ashiba, A
Munemasa, M
Sunami, K
Hiramatsu, Y
Ishimaru, F
Niiya, K
Yoshino, T
Harada, M
机构
[1] Okayama Univ, Sch Med, Dept Internal Med 2, Okayama 7008558, Japan
[2] Okayama Univ, Sch Med, Dept Pathol 2, Okayama 7008558, Japan
关键词
chronic active Epstein-Barr virus infection; allogeneic peripheral blood stem cell transplantation; myeloablative conditioning regimen; EBV-specific CTL;
D O I
10.1038/sj.bmt.1702600
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The prognosis of chronic active Epstein-Barr virus infection (CAEBV) is very poor. We describe a 24-year-old male with severe CAEBV who was treated with allogeneic peripheral blood stem cell transplantation (allo-PBSCT), On admission, EBER-1 in lymphocytes infiltrating the liver, EBV-DNA in peripheral blood mononuclear cells (PBMC) and monoclonal NK cell proliferation were confirmed. After unsuccessful chemotherapy, he received an allo-PBSCT from his HLA-identical sister. Although he died of pulmonary hemorrhage on day +19, EBV-DNA was undetectable by PCR in PBMC, and the post-mortem liver showed no EBER-1-positive lymphocytes. This experience suggests that EBV-positive lymphocytes in CAEBV may be eradicated by allo-PBSCT, thereby raising the possibility of a new treatment modality.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 22 条
[1]  
CHAMPLIN R, 1999, CURR OPIN ONCOL, V1, P87
[2]   EPSTEIN-BARR-VIRUS DNA IN CEREBROSPINAL-FLUID FROM PATIENTS WITH AIDS-RELATED PRIMARY LYMPHOMA OF THE CENTRAL-NERVOUS-SYSTEM [J].
CINQUE, P ;
BRYTTING, M ;
VAGO, L ;
CASTAGNA, A ;
PARRAVICINI, C ;
ZANCHETTA, N ;
MONFORTE, AD ;
WAHREN, B ;
LAZZARIN, A ;
LINDE, A .
LANCET, 1993, 342 (8868) :398-401
[3]  
Gross TG, 1996, BONE MARROW TRANSPL, V17, P741
[4]  
Harada M, 1996, J Hematother, V5, P63, DOI 10.1089/scd.1.1996.5.63
[5]   A CLUSTER OF PATIENTS WITH A CHRONIC MONONUCLEOSIS-LIKE SYNDROME - IS EPSTEIN-BARR-VIRUS THE CAUSE [J].
HOLMES, GP ;
KAPLAN, JE ;
STEWART, JA ;
HUNT, B ;
PINSKY, PF ;
SCHONBERGER, LB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (17) :2297-2302
[6]   Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis [J].
Imashuku, S ;
Naya, M ;
Yamori, M ;
Nakabayashi, Y ;
Hojo, M ;
Kihara, A ;
Tabata, Y ;
Akioka, C ;
Hibi, S ;
Todo, S .
BONE MARROW TRANSPLANTATION, 1997, 19 (10) :1059-1060
[7]   GANCICLOVIR FOR CHRONIC ACTIVE EPSTEIN-BARR-VIRUS INFECTION [J].
ISHIDA, Y ;
YOKOTA, Y ;
TAUCHI, H ;
FUKUDA, M ;
TAKAOKA, T ;
HAYASHI, M ;
MATSUDA, H .
LANCET, 1993, 341 (8844) :560-561
[8]   CHRONIC ACTIVE EPSTEIN-BARR-VIRUS INFECTION IN CHILDREN IN JAPAN [J].
ISHIHARA, S ;
OKADA, S ;
WAKIGUCHI, H ;
KURASHIGE, T ;
MORISHIMA, T ;
KAWAHA, K .
ACTA PAEDIATRICA, 1995, 84 (11) :1271-1275
[9]  
Kawa K, 2000, INT J HEMATOL, V71, P108
[10]  
KEISEI KH, 1987, LANCET, V1, P154